Greece - Buy the Di...
StemCells Inc. (STEM: NASDAQ)
$1.00 -0.04 | -3.86%
02/09/12 - 03:55 PM ET
672.54K / 206.00K
Vol / Avg. Vol:1.06 / 1.04
Open / Prev. Close:0.95 - 1.07
Today's Range:0.70 - 9.82
52 Wk Range:308.80%
Performance YTD:TheStreet Rating:
Portfolios with STEM
- Portfolio NameUser Type
- Contributor5 Biggest Drug-Stock Losers...
- Contributor16 Small-Cap Stocks in Dang...
- UserAdam's Watchlist
- ContributorStem Cell Stocks
- Contributor14 Penny Stocks Get Delisti...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- Usergellis1360 Portfolio 1
- UserStocks I would like to buy ...
- UserBesV Portfolio 1
Latest STEM Headlines from TheStreet
- 5 Biggest Drug-Stock Losers of 2011 12.21.11 | 06:12 am
- Geron's Stem Cell Bust Leaves Investors Holding the Bag 11.15.11 | 09:11 am
- StemCells Stock Gaps Down On Today's Open (STEM) 04.08.11 | 09:04 am
- StemCells, Inc. Adds Serum-Free And Animal Component-Free Cell Culture Supplements To Its SC Proven(R) Product Portfolio 03.29.11 | 09:03 am
- StemCells, Inc. Further Expands SC Proven(R) Product Portfolio With New Line Of Purified Whole Cell Lysate Reagents 03.22.11 | 09:03 am
- StemCells, Inc. Initiates World's First Neural Stem Cell Trial In Spinal Cord Injury 03.14.11 | 09:03 am
- StemCells, Inc. Reports Fourth Quarter And Fiscal 2010 Financial Results And Business Highlights 03.11.11 | 09:03 am
- StemCells, Inc. To Present At ROTH Capital Partners Growth Conference 03.08.11 | 09:03 am
- StemCells, Inc. To Present At New York Stem Cell Summit 02.23.11 | 09:02 am
- StemCells, Inc. Completes Dosing In Second Trial Of HuCNS-SC(R) Neural Stem Cells 02.17.11 | 09:02 am
Press Releases for STEM
Partner Headlines for STEM
- StemCells Announces Proposed Public Offering of Common Stock and Warrants - Benzinga 12.15.11 | 04:12 pm
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- StemCells Down 10% As Company Discontinues Batten Disease Program (STEM) - Benzinga 04.08.11 | 01:04 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Just One Stock: The Biopharma Veteran Facing a Landmark Stem Cell Trial - Seeking Alpha 01.28.11 | 08:01 pm
- Aastrom Biosciences' Uptrend Fueled by More Than Just Market Momentum - Seeking Alpha 12.29.10 | 05:12 am
- 3 Technology Sector Picks for 2011 - Seeking Alpha 12.21.10 | 07:12 am
- StemCells plans chronic spinal cord injury trial - Reuters 11.15.10 | 07:11 am
- China Analyst: 10 Pharma Stocks With Highest Growth Potential - Seeking Alpha 10.08.10 | 06:10 am
- Deutsche Bank Dents Dow's Gains - Fox Business 09.09.10 | 04:09 pm





